NASDAQ : JAZZ
Jazz Pharmaceuticals plc — Financial statements
Healthcare · Biotechnology · Ireland
Last price 207.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.49B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Jazz Pharmaceuticals plc (JAZZ) reported revenue of 4.60B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 4.60B | 4.27B | 4.07B | 3.83B | 3.66B | 3.09B |
| Cost of Revenue | 397.85M | 355.35M | 310.70M | 284.13M | 267.12M | 217.68M |
| Gross Profit | 4.20B | 3.91B | 3.76B | 3.55B | 3.39B | 2.88B |
| Selling, General & Admin | 1.54B | 1.50B | 1.42B | 1.31B | 1.40B | 1.40B |
| Research & Development | 774.39M | 741.49M | 851.06M | 818.39M | 555.41M | 476.33M |
| Amortization of Goodwill & Intangibles | 680.46M | 654.66M | 627.31M | 608.28M | 599.17M | 525.77M |
| Operating Expenses | 2.99B | 2.89B | 2.89B | 2.73B | 2.55B | 2.40B |
| Operating Income | 1.21B | 1.02B | 864.14M | 816.23M | 839.14M | 475.26M |
| Interest Expense | -258.65M | -280.85M | -344.40M | -354.54M | -299.74M | -280.57M |
| Interest & Investment Income | 87.70M | 85.80M | 106.30M | 65.10M | 11.50M | 1.80M |
| Earnings From Equity Investments | -232.00K | -732.00K | -1.66M | -3.01M | -9.92M | -714.00K |
| Currency Exchange Gain (Loss) | 1.83M | -2.57M | -8.18M | 8.79M | -19.01M | -4.35M |
| EBT Excluding Unusual Items | 1.16B | 819.72M | 616.21M | 532.57M | 521.97M | 191.43M |
| Merger & Restructuring Charges | -164.05M | -176.95M | -137.51M | -156.95M | -326.88M | -304.99M |
| Asset Writedown | -61.70M | -133.65M | ||||
| Legal Settlements | -151.50M | -323.50M | ||||
| Pretax Income | 727.51M | -628.59M | 468.69M | 294.92M | -382.70M | -113.55M |
| Income Tax Expense | -213.24M | -272.44M | -91.43M | -119.91M | -158.65M | 216.12M |
| Earnings From Continuing Operations | 940.75M | -356.15M | 560.12M | 414.83M | -224.06M | -329.67M |
| Net Income | 940.75M | -356.15M | 560.12M | 414.83M | -224.06M | -329.67M |
| Net Income to Common | 940.75M | -356.15M | 560.12M | 414.83M | -224.06M | -329.67M |
| Shares Outstanding (Basic) | 61.68M | 60.98M | 61.84M | 63.29M | 62.54M | 59.69M |
| Shares Outstanding (Diluted) | 64.33M | 60.98M | 66.01M | 72.07M | 62.54M | 59.69M |
| EPS (Basic) | 15.25 | -5.84 | 9.06 | 6.55 | -3.58 | -5.52 |
| EPS (Diluted) | 14.63 | -5.84 | 8.65 | 6.10 | -3.58 | -5.52 |
| Free Cash Flow | 1.59B | 1.30B | 1.36B | 1.07B | 1.24B | 750.87M |
| Free Cash Flow Per Share | 24.74 | 21.27 | 20.57 | 14.82 | 19.87 | 12.58 |
| Gross Margin | 91.35% | 91.67% | 92.36% | 92.59% | 92.70% | 92.97% |
| Operating Margin | 26.28% | 23.86% | 21.24% | 21.29% | 22.93% | 15.36% |
| Profit Margin | 20.45% | -8.34% | 13.77% | 10.82% | -6.12% | -10.65% |
| Free Cash Flow Margin | 34.58% | 30.39% | 33.37% | 27.86% | 33.97% | 24.27% |
| EBITDA | 1.93B | 1.71B | 1.52B | 1.45B | 1.47B | 1.03B |
| EBITDA Margin | 41.88% | 40.17% | 37.46% | 37.95% | 40.13% | 33.22% |
| D&A For EBITDA | 718.00M | 696.30M | 660.07M | 638.70M | 629.47M | 552.48M |
| EBIT | 1.21B | 1.02B | 864.14M | 816.23M | 839.14M | 475.26M |
| EBIT Margin | 26.28% | 23.86% | 21.24% | 21.29% | 22.93% | 15.36% |
| Revenue as Reported | 4.60B | 4.27B | 4.07B | 3.83B | 3.66B | 3.09B |
| Advertising Expenses | 105.60M | 107.40M | 92.20M | 108.80M | 161.50M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.62B | 1.39B | 2.41B | 1.51B | 881.48M | 591.45M |
| Short-Term Investments | 580.00M | 1.05B | 580.00M | 120.00M | ||
| Trading Asset Securities | 959.00K | 3.78M | ||||
| Cash & Short-Term Investments | 2.20B | 2.44B | 2.99B | 1.63B | 881.48M | 591.45M |
| Receivables | 880.90M | 830.75M | 716.76M | 705.79M | 651.49M | 563.36M |
| Inventory | 443.00M | 416.96M | 480.44M | 597.04M | 714.06M | 1.07B |
| Prepaid Expenses | 200.00M | 152.48M | 177.41M | 185.48M | 91.91M | 131.41M |
| Other Current Assets | 244.50M | 323.95M | 260.58M | 317.02M | 267.19M | 252.39M |
| Total Current Assets | 3.97B | 4.17B | 4.63B | 3.44B | 2.61B | 2.61B |
| Property, Plant & Equipment | 264.10M | 258.74M | 227.00M | 234.99M | 301.38M | 343.42M |
| Long-Term Investments | 4.30M | 4.30M | 4.33M | 4.70M | 5.50M | 5.00M |
| Goodwill | 1.80B | 1.83B | 1.72B | 1.75B | 1.69B | 1.83B |
| Other Intangible Assets | 4.03B | 4.43B | 4.76B | 5.42B | 5.79B | 7.15B |
| Long-Term Deferred Tax Assets | 926.40M | 869.13M | 560.25M | 477.83M | 376.25M | 311.10M |
| Long-Term Deferred Charges | 6.60M | 7.55M | 9.49M | 6.48M | 9.25M | 12.03M |
| Other Long-Term Assets | 82.00M | 94.73M | 110.15M | 62.76M | 49.64M | 35.81M |
| Total Assets | 11.08B | 11.66B | 12.01B | 11.39B | 10.84B | 12.30B |
| Accounts Payable | 128.50M | 122.06M | 77.87M | 102.75M | 90.76M | 100.30M |
| Accrued Expenses | 968.50M | 974.51M | 821.98M | 748.21M | 757.86M | 588.41M |
| Current Portion of Long-Term Debt | 1.02B | 1.03B | 31.00M | 604.95M | 31.00M | 46.23M |
| Current Portion of Leases | 14.30M | 14.72M | 14.78M | 19.45M | 15.94M | 15.76M |
| Current Income Taxes Payable | 55.90M | 56.39M | 18.76M | 35.07M | 7.72M | 9.61M |
| Current Unearned Revenue | 463.00K | 2.09M | ||||
| Other Current Liabilities | 47.20M | 44.95M | 74.19M | 26.26M | 29.46M | 46.90M |
| Total Current Liabilities | 2.23B | 2.24B | 1.04B | 1.54B | 933.19M | 809.30M |
| Long-Term Debt | 3.33B | 4.33B | 6.08B | 5.11B | 5.69B | 6.02B |
| Long-Term Leases | 43.60M | 54.33M | 43.50M | 64.26M | 77.05M | 93.47M |
| Long-Term Unearned Revenue | 463.00K | |||||
| Long-Term Deferred Tax Liabilities | 528.90M | 594.47M | 676.74M | 847.71M | 944.34M | 1.30B |
| Other Long-Term Liabilities | 140.90M | 121.08M | 82.05M | 96.30M | 101.60M | 110.73M |
| Total Liabilities | 6.28B | 7.34B | 7.92B | 7.66B | 7.75B | 8.33B |
| Common Stock | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K | |
| Additional Paid-In Capital | 4.33B | 4.24B | 3.91B | 3.70B | 3.48B | 3.53B |
| Retained Earnings | 1.13B | 646.18M | 1.13B | 878.66M | 733.59M | 830.23M |
| Comprehensive Income & Other | -661.90M | -568.07M | -947.14M | -841.62M | -1.12B | -399.83M |
| Shareholders' Equity | 4.80B | 4.32B | 4.09B | 3.74B | 3.09B | 3.97B |
| Total Liabilities & Equity | 11.08B | 11.66B | 12.01B | 11.39B | 10.84B | 12.30B |
| Total Debt | 4.41B | 5.43B | 6.17B | 5.80B | 5.82B | 6.17B |
| Net Cash (Debt) | -2.21B | -2.99B | -3.17B | -4.17B | -4.94B | -5.58B |
| Net Cash Per Share | -34.35 | -48.96 | -48.07 | -57.86 | -78.92 | -93.53 |
| Filing Date Shares Outstanding | 64.91M | 61.56M | 60.73M | 62.35M | 63.33M | 61.74M |
| Total Common Shares Outstanding | 64.80M | 61.44M | 60.63M | 62.26M | 63.21M | 61.63M |
| Working Capital | 1.74B | 1.92B | 3.59B | 1.90B | 1.67B | 1.80B |
| Book Value Per Share | 74.10 | 70.30 | 67.52 | 60.03 | 48.82 | 64.34 |
| Tangible Book Value | -1.03B | -1.94B | -2.38B | -3.43B | -4.40B | -5.01B |
| Tangible Book Value Per Share | -15.86 | -31.58 | -39.22 | -55.16 | -69.63 | -81.36 |
| Land | 71.80M | 72.23M | 71.90M | 70.91M | 68.94M | 64.01M |
| Machinery | 130.50M | 129.33M | 116.14M | 107.57M | 100.48M | 99.72M |
| Construction In Progress | 70.50M | 49.63M | 34.49M | 18.66M | 67.39M | 86.51M |
| Leasehold Improvements | 65.60M | 63.57M | 70.20M | 67.72M | 64.78M | 66.32M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 940.75M | -356.15M | 560.12M | 414.83M | -224.06M | -329.67M |
| Depreciation & Amortization | 718.00M | 696.30M | 660.07M | 638.70M | 629.47M | 552.48M |
| Loss (Gain) From Sale of Assets | 37.70M | |||||
| Asset Writedown & Restructuring Costs | 119.46M | 947.86M | 10.00M | 80.01M | 577.80M | |
| Stock-Based Compensation | 306.73M | 291.13M | 248.04M | 226.84M | 222.00M | 189.01M |
| Provision & Write-off of Bad Debts | 34.01M | 19.11M | 27.76M | 11.11M | 14.54M | 19.67M |
| Other Operating Activities | -409.48M | -261.38M | -33.36M | -75.05M | 4.63M | 394.97M |
| Change in Accounts Receivable | -168.18M | -106.28M | -21.11M | -51.88M | -90.14M | -92.73M |
| Change in Inventory | -131.84M | -86.04M | -45.54M | -13.42M | -49.64M | -48.86M |
| Change in Accounts Payable | 40.45M | 39.85M | -20.07M | 9.60M | -11.22M | 57.02M |
| Change in Unearned Revenue | -2.09M | -2.31M | ||||
| Change in Income Taxes | -22.38M | 37.22M | -14.74M | 25.22M | -1.69M | -15.52M |
| Change in Other Net Operating Assets | 233.54M | 134.14M | 24.75M | -173.96M | 164.69M | 54.45M |
| Operating Cash Flow | 1.66B | 1.36B | 1.40B | 1.09B | 1.27B | 778.51M |
| Capital Expenditures | -69.75M | -58.75M | -38.07M | -23.96M | -29.05M | -27.64M |
| Sale of Property, Plant & Equipment | 28.17M | 28.17M | ||||
| Cash Acquisitions | 47.00K | -858.05M | -6.23B | |||
| Divestitures | 53.00M | |||||
| Sale (Purchase) of Intangibles | -203.00M | -151.00M | -10.00M | -19.00M | -469.15M | -17.89M |
| Investment in Securities | -100.17M | -470.27M | -460.12M | -120.10M | -1.04M | 1.07B |
| Investing Cash Flow | -221.91M | -1.51B | -508.19M | -163.06M | -446.23M | -5.21B |
| Long-Term Debt Issued | 980.77M | 5.19B | ||||
| Total Debt Issued | 980.77M | 5.19B | ||||
| Long-Term Debt Repaid | -781.00M | -606.00M | -31.00M | -582.01M | -1.32B | |
| Total Debt Repaid | -1.03B | -781.00M | -606.00M | -31.00M | -582.01M | -1.32B |
| Net Debt Issued (Repaid) | -1.03B | -781.00M | 374.77M | -31.00M | -582.01M | 3.87B |
| Issuance of Common Stock | 141.46M | 107.86M | 20.65M | 46.46M | 98.02M | 135.26M |
| Repurchase of Common Stock | -118.94M | -200.24M | -369.18M | -320.71M | -45.50M | -35.60M |
| Other Financing Activities | -5.72M | |||||
| Financing Cash Flow | -1.01B | -873.38M | 20.52M | -305.25M | -529.49M | 3.97B |
| Foreign Exchange Rate Adjustments | -745.00K | 6.55M | -1.68M | 1.14M | -6.22M | -3.21M |
| Net Cash Flow | 429.94M | -1.02B | 906.55M | 624.83M | 290.03M | -466.32M |
| Free Cash Flow | 1.59B | 1.30B | 1.36B | 1.07B | 1.24B | 750.87M |
| Free Cash Flow Margin | 34.58% | 30.39% | 33.37% | 27.86% | 33.97% | 24.27% |
| Free Cash Flow Per Share | 24.74 | 21.27 | 20.57 | 14.82 | 19.87 | 12.58 |
| Levered Free Cash Flow | 1.43B | 1.35B | 1.44B | 1.06B | 1.12B | -138.27M |
| Unlevered Free Cash Flow | 1.59B | 1.53B | 1.65B | 1.28B | 1.31B | 37.09M |
| Cash Interest Paid | 248.55M | 248.55M | 314.82M | 333.11M | 270.67M | 138.27M |
| Cash Income Tax Paid | 121.81M | 121.81M | 114.91M | 177.88M | 94.68M | 271.22M |
| Change in Working Capital | -48.40M | 18.90M | -76.72M | -204.44M | 9.90M | -47.95M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 14.02B | 10.33B | 7.44B | 7.74B | 10.03B | 7.83B |
| Enterprise Value | 16.23B | 13.71B | 11.03B | 11.94B | 14.95B | 13.57B |
| Last Close Price | 215.98 | 170.00 | 123.15 | 123.00 | 159.31 | 127.40 |
| PE Ratio | 14.76 | 13.29 | 18.67 | |||
| Forward PE | 12.94 | 7.67 | 5.72 | 6.29 | 8.54 | 8.23 |
| PS Ratio | 3.05 | 2.42 | 1.83 | 2.02 | 2.74 | 2.53 |
| PB Ratio | 2.91 | 2.39 | 1.82 | 2.07 | 3.25 | 1.98 |
| P/FCF Ratio | 8.81 | 7.96 | 5.48 | 7.25 | 8.07 | 10.43 |
| P/OCF Ratio | 8.44 | 7.62 | 5.33 | 7.09 | 7.89 | 10.06 |
| PEG Ratio | 0.24 | 0.55 | 0.37 | 0.50 | 1.14 | 0.61 |
| EV/Sales Ratio | 3.53 | 3.21 | 2.71 | 3.12 | 4.08 | 4.39 |
| EV/EBITDA Ratio | 8.42 | 8.00 | 7.24 | 8.21 | 10.18 | 13.20 |
| EV/EBIT Ratio | 13.42 | 13.47 | 12.77 | 14.63 | 17.81 | 28.55 |
| EV/FCF Ratio | 10.20 | 10.57 | 8.12 | 11.18 | 12.03 | 18.07 |
| Debt / Equity Ratio | 0.92 | 1.26 | 1.51 | 1.55 | 1.89 | 1.56 |
| Debt / EBITDA Ratio | 2.25 | 3.11 | 3.97 | 3.92 | 3.90 | 5.84 |
| Debt / FCF Ratio | 2.77 | 4.18 | 4.54 | 5.43 | 4.68 | 8.22 |
| Net Debt / Equity Ratio | 0.46 | 0.69 | 0.78 | 1.12 | 1.60 | 1.41 |
| Net Debt / EBITDA Ratio | 1.15 | 1.74 | 2.08 | 2.87 | 3.36 | 5.43 |
| Net Debt / FCF Ratio | 1.39 | 2.30 | 2.34 | 3.90 | 3.97 | 7.43 |
| Asset Turnover | 0.42 | 0.36 | 0.35 | 0.34 | 0.32 | 0.33 |
| Inventory Turnover | 0.84 | 0.79 | 0.58 | 0.43 | 0.30 | 0.37 |
| Quick Ratio | 1.38 | 1.46 | 3.57 | 1.52 | 1.64 | 1.43 |
| Current Ratio | 1.78 | 1.86 | 4.46 | 2.24 | 2.79 | 3.23 |
| Return on Equity (ROE) | 22.11% | -8.47% | 14.31% | 12.16% | -6.35% | -8.65% |
| Return on Assets (ROA) | 6.86% | 5.38% | 4.61% | 4.59% | 4.53% | 3.15% |
| Return on Invested Capital (ROIC) | 17.17% | 13.97% | 11.39% | 10.25% | 9.55% | 7.13% |
| Return on Capital Employed (ROCE) | 13.70% | 10.80% | 7.90% | 8.30% | 8.50% | 4.10% |
| Earnings Yield | 6.78% | -3.45% | 7.52% | 5.36% | -2.23% | -4.21% |
| FCF Yield | 11.35% | 12.56% | 18.24% | 13.79% | 12.39% | 9.59% |
| Buyback Yield / Dilution | -5.40% | 7.61% | 8.41% | -15.23% | -4.77% | -5.62% |